Eliot A. Brinton

Eliot A. Brinton, MD

Languages spoken: Spanish, English

Board Certification

  • American Board of Internal Medicine (Internal Medicine)

Education History

Undergraduate University of Utah
 BS
Professional Medical University of Utah
 MD
Internship Duke University Medical Center
 Intern
Residency Duke University Medical Center
 Resident
Fellowship University of Washington School of Medicine
 Fellow

Selected Publications

Journal Article

  1. Brinton E (2005). Controversies in dyslipidemias: atheroprevention in diabetes and insulin resistance. Annals of the New York Academy of Sciences, 1055, 159-78. (Read full article)
  2. Kuivenhoven JA, Hovingh GK, van Tol A, Jauhiainen M, Ehnholm C, Fruchart JC, Brinton EA, Otvos JD, Smelt AH, Brownlee A, Zwinderman AH, Hayden MR, Kastelein J (2003). Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size. Atherosclerosis, 171(2), 311-9. (Read full article)
  3. Hopkins PN, Wu LL, Hunt SC, Brinton E (2005). Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. Journal of the American College of Cardiology, 45(7), 1003-12. (Read full article)
  4. Manson JE, Bassuk SS, Harman SM, Brinton EA, Cedars MI, Lobo R, Merriam GR, Miller VM, Naftolin F, Santoro (2006). Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause (New York, N.Y.), 13(1), 139-47. (Read full article)

Editorial

  1. Brinton EA, Nanjee MN, Hopkins P (2004). Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?. Journal of the American College of Cardiology, 43(12), 2233-5. (Read full article)